Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

18 Dec 2012 07:00

RNS Number : 7285T
Impellam Group plc
18 December 2012
 



Impellam Group plc ("Impellam" or the "Company" or "Group")

 

Pre close trading statement

 

Impellam is pleased to announce that trading during the second half of the year has been stable, despite continuing difficult economic environments in its key UK and US markets. The Group is expecting year on year revenue growth across all of its staffing businesses.

Increasing buyer sophistication and the increased use of framework agreements has resulted in further pricing pressure within certain business areas. As a result, we are expecting a small percentage reduction in full year net fee income. Operating profits, before share option charges and before restructuring charges that are expected to be around £5.5 million, are therefore likely to be around £3.0 million lower than the prior year. Adjusted EPS is expected to be broadly flat as a result of lower interest charges, driven by a reduction in the Group's debt and a reduction in the number of shares in issue following several share buy backs completed during the year.

Following an extensive restructuring of the Group, the cost base has been reduced which will deliver further benefits as we enter 2013. This, coupled with contract wins and our bias towards temporary staffing relative to permanent placement, provides a degree of resilience to the Group's earnings and cash generation and we therefore expect to see a return to operating profit growth in 2013.

 

During the year, the Group commenced payment of a dividend and also returned cash to shareholders through a programme of share buy backs in the market. The return of cash to shareholders remains a key objective for the Group and, to that end, the Board is considering the payment of a one off special dividend of not less than £15.0 million following release of the preliminary statement in February. Further details of this will be announced in due course.

 

Enquiries: For further information please contact the appropriate individual below.

 

 

Impellam Group plc

Andrew Wilson

Andrew Burchall Tel: 01582 692658

 

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

 

 

Threadneedle Communications

John Coles Tel: 020 7653 9848

 

 

 

Note to Editors:

 

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,200 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 19th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEDLFFLLFEFBX
Date   Source Headline
22nd Dec 201710:12 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSTransaction in Own Shares
18th Dec 20177:00 amRNSShare Purchase Plan
15th Nov 20173:38 pmRNSTrading Statement
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20174:51 pmRNSDirectorate Change
27th Jul 20177:00 amRNSHalf-year Report
28th Jun 201710:49 amRNSResult of AGM
28th Apr 20172:12 pmRNSDirector/PDMR Shareholding
16th Mar 20175:09 pmRNSAnnual Financial Report & Dividend Record Date
9th Mar 20177:00 amRNSPreliminary Results - Unaudited
15th Dec 20167:00 amRNSTrading Update
28th Jul 20167:00 amRNSHalf-year Report
29th Jun 20169:31 amRNSResult of AGM
5th May 20167:00 amRNSQ1 Trading Update
7th Apr 201611:16 amRNSHolding(s) in Company
5th Apr 20163:21 pmRNSIssue of Equity
30th Mar 20162:11 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSDividend Record Date
3rd Mar 20167:00 amRNSPreliminary Results - Unaudited
12th Jan 20168:19 amRNSTrading update and joint broker - replacement
12th Jan 20167:00 amRNSTrading update and appointment of joint broker
14th Dec 201512:15 pmRNSDirector/PDMR Shareholding
11th Dec 20158:01 amRNSTotal Voting Rights
8th Dec 20157:00 amRNSAcquisition and Trading Update
16th Nov 201511:35 amRNSResult of General Meeting
30th Oct 20157:00 amRNSPosting of Circular and Notice of General Meeting
27th Oct 20155:25 pmRNSProposed change in nature of Dividend
2nd Sep 20157:00 amRNSGrant of Options
30th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 20159:00 amRNSPosting of circular
30th Jun 201510:04 amRNSResult of AGM
4th Jun 20157:00 amRNSNotice of AGM and change to dividend timetable
17th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 20154:35 pmRNSIssue of Equity & Director's Shareholding
6th Mar 20159:00 amRNSAnnual Financial Report
3rd Mar 20157:00 amRNSPreliminary Results - Unaudited
16th Jan 20157:00 amRNSPre-Close Trading Update
12th Jan 20157:00 amRNSDirectorate Change
16th Dec 201410:30 amRNSDirectorate Change
13th Nov 20147:30 amRNSHolding(s) in Company
10th Nov 20141:03 pmRNSCompletion of Acquisition and Directorate Change
7th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20148:00 amRNSDirectors' Dealings
4th Nov 20147:10 amRNSPlacing to raise £15 million
4th Nov 20147:00 amRNSAcquisition of Lorien
30th Jul 20147:00 amRNSHalf Yearly Report
18th Jun 20143:44 pmRNSResult of AGM
15th May 20144:00 pmRNSDeath of a Director
7th May 20147:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.